Happy New Year to all longs.

May we soon be joined by many new investors to power this promising covid therapy and harness this virus and pandemic once and for all.

This is very interesting---

I picked this up from the Eversana website - this analysis is not Resverlogix specific, but in my opinion the graphics and logic displayed in the following presentation are very similar to those displayed in the 12/16 corporate update. Yeah, the presentation is software driven, but I can't help think that Eversana was more than passively involved in the last corporate update and probably in assembling the June, 2021 presentation also. Two well prepared professional presentations that pushed all the right buttons. Didn't DM say that RVX and Eversana meet a couple of times per week. I would love to view the ValuationCaseStudy for Apabetalone - as DM stated - he is planning on a financial update early this year - My guess is Eversana is putting it together.

Here is the link - Chicagoest

://www.eversana.com/wp-content/uploads/dlm_uploads/2021/01/APAC_ValuationCaseStudy_EVERSANA_011421.pdf